Amy Chappell
Net worth: 1 105 $ as of 2026-09-29
Net worth: 1 105 $ as of 2026-09-29
Amy S.
Chappell is currently an Independent Director at BioVie, Inc. since 2025 and Chief Medical Officer at Solaxa, Inc. since 2024.
Formerly, Dr. Chappell was Chief Medical Officer at Climb Bio, Inc. from 2020 to 2021.
Education includes undergraduate studies at Antioch College and a doctorate from The Indiana University School of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOVIE INC. CLASS A 0.01% | 2026-08-30 | 727 ( 0.01% ) | 1 105 $ | 2026-09-29 |
| Companies | Position | Start |
|---|---|---|
| BIOVIE INC. | Director/Board Member | 2025-07-21 |
| Companies | Position | End |
|---|---|---|
| CLIMB BIO, INC. | Chief Tech/Sci/R&D Officer | 2021-12-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
BioVie, Inc.
BioVie, Inc. BiotechnologyHealth Technology Develops drug therapies for chronic debilitating conditions | Health Technology |
Antioch College
Antioch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Indiana University School of Medicine
The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions